Vol. I · No. 27

The considered read on the medspa world

TreatmentsProfessional & trade

Dermal Filler Areas: Consumer Guide

Explore dermal filler treatment areas—chin, under-eyes, nasolabial folds, and more—in this consumer guide grounded in recent clinical research.

By
Ian Gauntt, RN, BSN
Filed under
Treatments
Published
August 18, 2026
Sources cited
8
Evidence
Tier 2 · Professional & trade
Lips receive an injection of filler.

Key Takeaways

  • Injectable fillers can address a wide range of areas—from the chin and under-eyes to nasolabial folds and stretch marks—using different filler types tailored to each zone.
  • Both hyaluronic acid and calcium hydroxylapatite fillers have clinical evidence supporting their use, but the right choice depends on the treatment area and individual anatomy.
  • Technique matters as much as product: specialized injection approaches (such as dilution methods or layered placement) are associated with improved outcomes and reduced complications in recent studies.
  • Results are generally temporary and vary by individual, area treated, and filler type, so realistic expectations and follow-up planning are essential.
  • Always consult a licensed, experienced medical professional before pursuing any filler treatment, as risks including bruising, swelling, and rare vascular complications exist across all areas.

What Is a Dermal Filler and How Does It Work?

Dermal fillers are injectable substances that physically add volume beneath the skin to smooth wrinkles, restore lost fullness, or reshape facial contours. They work by occupying space in the dermis or subcutaneous tissue — and, depending on the material, by triggering the body's own collagen-building response over time.

The core mechanism

Most fillers fall into a few material categories, each acting differently once injected:

  • Hyaluronic acid (HA): A sugar molecule that occurs naturally in the body. HA fillers attract and hold water, which creates immediate volume. A randomized, double-blind controlled trial comparing HA filler formulations for nasolabial folds confirmed measurable correction that persisted through the study period, with both monophasic and biphasic formulations producing significant improvement over baseline.
  • Calcium hydroxylapatite (CaHA): Tiny calcium-based microspheres suspended in a gel carrier. The gel provides immediate lift; the microspheres stimulate fibroblasts to produce new collagen as the carrier absorbs. Research on hybrid CaHA-HA formulations describes this dual-action profile — immediate volume plus a longer-term biostimulatory effect.
  • Collagen-crosslinked HA composites: Newer hybrid materials combine HA with collagen to improve structural support. A clinical evaluation of composite collagen-crosslinked HA found the material effective for infraorbital rejuvenation, with the collagen component adding mechanical stability beyond what standard HA alone provides.

What the research shows about results

Results are real. A six-month study tracking periorbital and perioral wrinkles after low-cross-linked HA injection found statistically significant improvements in skin quality and wrinkle depth (source) at follow-up — not just immediately after treatment. Duration varies by product, placement depth, and individual metabolism.

Placement matters enormously. A systematic review of chin augmentation techniques found that precise anatomical targeting — supraperiosteal versus subcutaneous injection planes — directly determines both the aesthetic outcome and the safety profile. The injector's knowledge of facial anatomy is not a secondary concern. It is the treatment.

A comprehensive review of minimally invasive facial rejuvenation techniques (source) characterizes fillers as among the most evidence-supported tools in aesthetic medicine, with a well-characterized safety profile when trained practitioners perform them.

Fillers add volume mechanically. Some rebuild collagen biologically. The evidence supports both effects — but outcomes depend heavily on material choice and injector skill.


This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified, licensed healthcare provider before pursuing any aesthetic procedure.

Which Areas of the Face and Body Can Dermal Fillers Treat?

Dermal fillers treat a wide range of facial and body areas — from deep structural concerns like chin projection to fine surface wrinkles around the eyes and mouth. The treatment zone has expanded well beyond lips and cheeks as clinical research documents results in areas that were once addressed only through surgery.

Face

The face remains the primary territory for filler use. Evidence covers several distinct zones:

  • Nasolabial folds. These lines run from the nose to the corners of the mouth. A randomized, double-blind controlled trial found that hyaluronic acid fillers produced significant correction of moderate-to-severe nasolabial folds, with both monophasic and biphasic formulations delivering measurable improvement — PMID 42528867.

  • Under-eye hollows (infraorbital area). The tear trough demands technical precision. Researchers testing a diluted hyaluronic acid approach specifically for infraorbital hollows reported meaningful volumization with a favorable safety profile — PMID 42488280. A separate study using a composite collagen–crosslinked hyaluronic acid filler in the same zone documented both clinical and experimental improvements in tissue quality — PMID 42448833.

  • Periorbital and perioral wrinkles. Fine lines around the eyes and mouth respond to low-cross-linked hyaluronic acid. A six-month follow-up study found measurable reductions in wrinkle severity and improvements in overall skin quality in both zones — PMID 42487104.

  • Chin. Non-surgical chin augmentation with injectable fillers is a growing application. A systematic review of volumetric chin techniques confirmed that fillers can reshape chin projection and contour without surgery — PMID 42545491.

  • Broader facial rejuvenation. A comprehensive review of minimally invasive facial techniques places fillers within a multi-modal framework, noting their role in restoring volume to midface, temples, and jawline — PMID 42441192.

Body

Body applications are less established but actively studied.

  • Labia majora. A hybrid calcium hydroxylapatite–hyaluronic acid filler showed improved volume and patient satisfaction in labia majora rejuvenation, an area where surgical options carry higher risk — PMID 42529489.

  • Stretch marks (striae distensae). Hyperdiluted calcium hydroxylapatite injected into stretch marks — combined with microneedling radiofrequency — produced visible improvement in a pilot study, though larger trials are needed — PMID 42434377.

Results vary by area, filler type, injector skill, and individual anatomy. A board-certified dermatologist or plastic surgeon can assess which zones suit your specific concerns.


This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before pursuing any cosmetic procedure.

What Does the Research Say About Safety and Effectiveness?

Most aesthetic treatments studied in peer-reviewed clinical research do show measurable improvements in the conditions they target — but results vary by treatment type, technique, and individual patient factors, and no outcome is guaranteed.

What the evidence shows, treatment by treatment:

  • Hyaluronic acid (HA) fillers for nasolabial folds: A randomized, double-blind, controlled trial found that both monophasic and biphasic HA fillers produced significant correction of moderate-to-severe nasolabial folds, with improvements sustained at follow-up and a favorable safety profile in both groups (PMID 42528867). Neither formulation proved dramatically superior — the difference came down to texture and injector preference.

  • Low-cross-linked HA for fine lines around the eyes and mouth: A six-month study found that patients treated with low-cross-linked HA showed measurable reductions in periorbital and perioral wrinkles alongside improvements in overall skin quality — not just wrinkle depth, but texture and hydration (PMID 42487104). Six months. That's the durability window the data actually supports.

  • Under-eye (infraorbital) rejuvenation: Two separate studies examined filler approaches for the tear trough area. One evaluated a composite collagen-crosslinked HA filler and found clinical improvements in infraorbital hollowing with an acceptable safety profile (PMID 42448833). Another tested a diluted Belotero Balance technique and reported patient satisfaction improvements alongside reduced hollowing (PMID 42488280). The under-eye area demands technical precision — outcomes depend heavily on injector skill.

  • Non-surgical chin augmentation with fillers: A systematic review of volumetric chin augmentation techniques found that injectable fillers can produce meaningful structural changes to chin projection and contour, with hyaluronic acid and calcium hydroxylapatite (CaHA) among the most studied agents (PMID 42545491).

  • Stretch marks (striae distensae): A pilot study combining hyperdiluted CaHA injections with fractional microneedling radiofrequency showed improvements in stretch mark appearance — but pilot studies are small and early-stage (PMID 42434377). Promising. Not proven at scale.

  • Minimally invasive facial rejuvenation broadly: A comprehensive review of minimally invasive techniques confirmed that botulinum toxin, dermal fillers, and energy-based devices each carry distinct evidence bases, risk profiles, and appropriate use cases — and that combining modalities often produces better outcomes than any single treatment alone (PMID 42441192).

The research is real. So are the limits of each study. Sample sizes, follow-up periods, and patient populations all shape what the data can actually tell you.


This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Consult a qualified, licensed healthcare professional before pursuing any aesthetic or cosmetic procedure.

What Techniques Do Providers Use—and Why Does It Matter?

The technique a provider chooses—and how precisely they execute it—directly shapes how natural your results look, how long they last, and how safe the procedure is. Technique is not a minor detail; it is the treatment.

Providers working with dermal fillers make decisions that go far deeper than product selection. Take nasolabial folds: a randomized controlled trial comparing monophasic and biphasic hyaluronic acid fillers found both corrected moderate-to-severe folds effectively, but the formulations behaved differently in tissue—meaning the same area can be treated with products that spread, lift, or integrate in distinct ways. Providers who understand those differences can match the product to your anatomy. Those who don't may produce results that look fine at two weeks and uneven at six months.

Injection depth matters just as much as product choice. For under-eye hollows—one of the most technically demanding areas on the face—researchers developed a specific diluted-filler protocol called the BB8 technique to reduce the risk of the Tyndall effect, a bluish discoloration that appears when filler sits too superficially. A separate study testing a composite collagen-crosslinked HA filler for the same infraorbital zone found measurable improvements in volume and skin quality—but only when placed at the correct tissue plane.

Several technique-driven distinctions shape your outcome:

  • Filler type and longevity: Calcium hydroxylapatite (CaHA) stimulates collagen over time, while hyaluronic acid (HA) fillers are reversible with an enzyme called hyaluronidase. A systematic review of chin augmentation found that technique selection—including injection plane and volume—directly influenced both aesthetic outcome and complication rate.
  • Combination approaches: Mixing CaHA with HA in a hybrid formulation for labia majora rejuvenation produced more uniform results than either product alone, researchers reported. The same logic applies to facial zones where tissue laxity and volume loss occur together.
  • Skin quality vs. volume: Low-cross-linked HA injected superficially improved periorbital and perioral wrinkles and overall skin texture at six months—a different goal, and a different technique, than structural volumizing.
  • Combined modalities: For stretch marks, combining hyperdiluted CaHA injections with fractional microneedling radiofrequency produced improvements neither treatment achieved alone, according to a pilot study.

A comprehensive review of minimally invasive facial rejuvenation concluded that provider skill and protocol selection are primary determinants of outcome. Ask your provider which technique they plan to use, why they chose it for your anatomy, and what the evidence base is. A qualified provider will answer directly.


This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a licensed healthcare professional before pursuing any aesthetic or cosmetic procedure.

What Should You Ask Before Booking a Filler Appointment?

Before you book a filler appointment, ask your provider which filler formulation they plan to use, why they chose it for your specific anatomy, and what the evidence says about how long results last in that treatment area. Those three questions alone will tell you more about a provider's competence than any before-and-after photo wall.

Why formulation matters more than brand name

Not all fillers behave the same way in tissue. Hyaluronic acid (HA) fillers come in monophasic and biphasic forms, and a randomized controlled trial found both types corrected moderate-to-severe nasolabial folds effectively, with differences in texture and integration that affect which product suits which area. A provider who can't explain that distinction is working from habit, not evidence.

Ask specifically:

  • What filler type are you using, and why for this area? HA fillers dominate most facial work, but calcium hydroxylapatite (CaHA) products serve different structural purposes — a systematic review of chin augmentation documents how technique and product selection interact to shape outcomes.
  • How diluted will the product be? Dilution is a real clinical variable. Research on infraorbital hollows shows that diluted HA delivered with a specific technique can reduce the bruising and lumpiness that concentrated product sometimes causes under thin under-eye skin.
  • What results should I realistically expect at six months? A six-month study on low-cross-linked HA showed measurable improvement in periorbital and perioral wrinkles and skin quality — but "measurable" is not the same as "dramatic." Ask your provider to quantify, not just reassure.

Questions about safety and anatomy

Vascular occlusion — where filler blocks a blood vessel — is the most serious acute complication. Ask your provider:

  • Do you have hyaluronidase on-site to dissolve HA filler in an emergency?
  • How many injections do you perform per week, and in which areas?
  • What is your protocol if I have a complication after I leave?

A comprehensive review of minimally invasive facial rejuvenation identifies injector experience and anatomical knowledge as primary safety variables — not the filler brand itself.

One more thing. Ask whether the provider tailors depth and volume to your facial structure or follows a fixed protocol. Anatomy varies. Results should too.


This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified, licensed healthcare professional before undergoing any cosmetic procedure.

What Are the Realistic Outcomes and Limitations?

Most aesthetic treatments produce measurable but partial improvements — not transformations — and results fade over months to years depending on the treatment type and how your body metabolizes the product.

That distinction matters before you book anything.

What the research actually shows:

  • Hyaluronic acid (HA) fillers for nasolabial folds produce clinically significant correction. A randomized controlled trial comparing monophasic and biphasic HA formulations found that both types achieved meaningful improvement, with differences between formulas being modest rather than dramatic. Neither formula eliminates folds permanently.

  • Under-eye (infraorbital) rejuvenation ranks among the trickier treatment zones. A clinical evaluation of composite collagen-HA filler for under-eye hollows showed measurable volumizing effects, and a separate diluted HA injection technique demonstrated visible improvement in tear-trough appearance — but both studies note the area carries higher risk of visible irregularities than other facial zones.

  • Skin quality improvements from low-cross-linked HA (a softer, more spreadable filler type used for surface hydration rather than volume) showed measurable reductions in periorbital and perioral wrinkles at six months in a prospective study. Six months. Not permanent.

  • Chin augmentation with injectable fillers can reshape facial proportions without surgery. A systematic review confirmed that non-surgical volumetric techniques produce consistent aesthetic outcomes — and also documents that vascular complications, though rare, are a real risk in this anatomical area.

  • Stretch marks (striae distensae) respond to treatment, but modestly. A pilot study combining hyperdiluted calcium hydroxylapatite injections with fractional microneedling radiofrequency (source) showed improvement in texture and appearance — pilot data, small sample, early findings. Stretch marks do not disappear.

The durability problem is real. A comprehensive review of minimally invasive facial rejuvenation techniques makes clear that maintenance treatments are the norm, not the exception. Your metabolism, sun exposure, and lifestyle all affect how long results last.

One honest summary: treatments work within limits. They soften. They restore some volume. They improve texture. They do not stop aging, and they do not replicate surgical outcomes. Anyone promising otherwise is selling something the evidence does not support.


This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual results vary. Consult a licensed healthcare professional before pursuing any aesthetic or cosmetic procedure.

FAQ

How long do dermal fillers typically last?

Duration varies by filler type, treatment area, and individual metabolism. Clinical studies on hyaluronic acid fillers for nasolabial folds and periorbital wrinkles report measurable results at six months, while chin augmentation and calcium hydroxylapatite treatments may last longer. Your provider can give area-specific estimates based on the product used.

Are dermal fillers safe for under-eye treatment?

The under-eye (infraorbital) area is considered technically demanding because the skin is thin and the tissue is delicate. Recent research on diluted filler techniques and composite collagen-crosslinked hyaluronic acid formulations reports favorable safety profiles when performed by experienced injectors, but the risk of bruising, swelling, and rare vascular events remains. A qualified provider assessment is essential.

What is the difference between hyaluronic acid and calcium hydroxylapatite fillers?

Hyaluronic acid (HA) fillers are gel-based, reversible with an enzyme called hyaluronidase, and used across many areas including lips, folds, and under-eyes. Calcium hydroxylapatite (CaHA) is a denser, biostimulatory filler often used for deeper volume loss, chin augmentation, and—in diluted form—skin quality improvement and stretch marks. Neither is universally 'better'; the right choice depends on the area and goal.

Can fillers treat stretch marks?

Emerging research suggests that hyperdiluted calcium hydroxylapatite injections combined with fractional microneedling radiofrequency may improve the appearance of stretch marks (striae distensae). A pilot study reported positive findings, but this remains an evolving area with limited long-term data. Discuss realistic expectations with a dermatologist or plastic surgeon.

Is non-surgical chin augmentation with filler a good alternative to implants?

A systematic review of injectable filler-based chin augmentation found that non-surgical volumetric techniques can effectively improve chin projection and facial harmony with a lower risk profile than surgery. However, results are temporary and may require maintenance. Surgical implants remain an option for those seeking permanent change, and a consultation with a board-certified provider can help determine which approach suits your anatomy and goals.

What questions should I ask my provider before getting fillers?

Key questions include: What filler product and technique will you use for my specific area? What are the most common side effects and how are they managed? Are you trained to handle complications such as vascular occlusion? How many treatments might I need, and how long will results last? What is your cancellation and follow-up policy? Always verify credentials and ask to see before-and-after examples from the provider's own patients.

This article is for general information and is not medical advice. Aesthetic treatment results vary by individual -- consult a licensed, qualified provider before pursuing any cosmetic procedure.

Sources

  1. T
  2. T
  3. T
  4. T
  5. T
  6. T
  7. T
  8. T

How we tier evidence →

No corrections to date · Report an error

MedSpa Daily is an editorial publication, not a medical provider. Nothing here is medical advice — consult a licensed clinician about your own care.

← Return to today's edition